Extended-Spectrum β-Lactamase - Producing &lt;i&gt;Klebsiella pneumonia &lt;/i&gt;and &lt;i&gt;Escherichia coli &lt;/i&gt;from Blood Cultures of Hospitalized Patients in Abakaliki Metropolis

Emmanuel, Nwakaeze; Anyim, C; J, N. Ngwu; Nwankwo, C.

doi:10.12691/ajidm-1-4-4

Cited by 2 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Extended-Spectrum Beta-Lactamases had this ability to hydrolyze all three generations of cephalosporins and aztreonam, but were inhibited by clavulanic acid (5,13). The results of our study showed that 118 Enterobacter isolates including E. aerogenes (31.36%), E. agglomerans (20.34%), E. cloacae (14.40%) and other Enterobacter spp.…”

Section: Discussionmentioning

confidence: 76%

Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens

Ramazanzadeh

Rouhi

Hosainzadegan

et al. 2016

Arch Clin Infect Dis

View full text Add to dashboard Cite

Background: Clinical significance of Extended-Spectrum Beta-Lactamases (ESBLs) production in Enterobacter spp. has not well been established. Objectives: This study was conducted to investigate the prevalence of ESBLs produced by Enterobacter spp. in clinical isolates. Materials and Methods:This descriptive cross-sectional study was performed during May 2010 to April 2012 in the city of Sanandaj, Kurdistan province, Iran. We did not include and directly contact the patient population, yet had access to two thousand patient specimens (urine, wound, respiratory tube, blood, cerebrospinal fluid and stool), which were collected from patients that had referred to various departments of two government hospitals of Toohid and Besat. As a result, 118 Enterobacter spp. isolates were identified and considered. The Clinical and laboratory standard institute (CLSI) Combined Disk Test (CDT) and polymerase chain reaction (PCR) were applied for detecting Enterobacter spp. Data were analyzed using the SPSS 11.5 software, Chi-square (x 2 ) test and

show abstract

Section: Discussionmentioning

confidence: 76%

Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens

Ramazanzadeh

Rouhi

Hosainzadegan

et al. 2016

Arch Clin Infect Dis

View full text Add to dashboard Cite

show abstract

“…Results of the present study are consistent with those from the literature highlighting that prevalence of ESBL strains of K. pneumoniae is significantly higher than that of E. coli, in the European countries and USA [55][56][57][58] . The situation is reversed in the countries of Asia, Africa and South America 43,46,59,60 .…”

Section: Resultsmentioning

confidence: 99%

Prevalence of Extended Spectrum Beta-Lactamases among Enterobacteriaceae Isolated from Intrahospital Patients in Serbia

Ciric¹,

Stanisic²,

Milosevic³

et al. 2018

Current Science

View full text Add to dashboard Cite

The aim of this study was to determine the prevalence of extended spectrum beta-lactamases (ESBLs) production in hospital strains of Enterobacteriaceae isolated from various clinical specimens (urine, blood and wound swabs) from hospitalized patients at the Military Medical Academy, Belgrade, Serbia. During six months of study, a total of 1034 isolates of Enterobacteriaceae were tested for antimicrobial susceptibility and screened for ESBL production according to standard methods. The overall prevalence of ESBL production in the hospital isolates of Enterobacteriaceae was 57.4%. Among the isolates, minimum frequency of resistance was found for amikacin (25.2%), and maximum for ampicillin (84.5%). The strain resistant to imipenem could not be isolated. Resistance to the tested antibiotics was higher in ESBL producers than non-producers (P < 0.05). Among Escherichia coli isolates, the prevalence of ESBL production was less than 50% (33.9%). ESBLs were most often produced by isolates of Serratia spp. (85.2%) and Klebsiella spp. (81.8%). Blood specimens were the most common sources of ESBL-producing isolates (84.0%). These findings might help clinicians in deciding the appropriate empirical treatment for intrahospital patients and emphasize the increasing problem of antimicrobial resistance in Serbia.

show abstract

Extended-Spectrum β-Lactamase - Producing <i>Klebsiella pneumonia </i>and <i>Escherichia coli </i>from Blood Cultures of Hospitalized Patients in Abakaliki Metropolis

Cited by 2 publications

References 25 publications

Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens

Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens

Prevalence of Extended Spectrum Beta-Lactamases among Enterobacteriaceae Isolated from Intrahospital Patients in Serbia

Contact Info

Product

Resources

About